CA3215414A1 - Therapeutic agent for gait disturbance - Google Patents
Therapeutic agent for gait disturbance Download PDFInfo
- Publication number
- CA3215414A1 CA3215414A1 CA3215414A CA3215414A CA3215414A1 CA 3215414 A1 CA3215414 A1 CA 3215414A1 CA 3215414 A CA3215414 A CA 3215414A CA 3215414 A CA3215414 A CA 3215414A CA 3215414 A1 CA3215414 A1 CA 3215414A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- patient
- therapeutic agent
- group
- gait disturbance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021060178 | 2021-03-31 | ||
| JP2021-060178 | 2021-03-31 | ||
| PCT/JP2022/016648 WO2022211052A1 (ja) | 2021-03-31 | 2022-03-31 | 歩行障害治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3215414A1 true CA3215414A1 (en) | 2022-10-06 |
Family
ID=83456587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3215414A Pending CA3215414A1 (en) | 2021-03-31 | 2022-03-31 | Therapeutic agent for gait disturbance |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240197724A1 (https=) |
| EP (1) | EP4316489A4 (https=) |
| JP (1) | JPWO2022211052A1 (https=) |
| KR (1) | KR20230165247A (https=) |
| CN (1) | CN117157075A (https=) |
| AU (1) | AU2022248664A1 (https=) |
| BR (1) | BR112023019899A2 (https=) |
| CA (1) | CA3215414A1 (https=) |
| IL (1) | IL307277A (https=) |
| TW (1) | TW202304444A (https=) |
| WO (1) | WO2022211052A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI316055B (https=) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| HRP20151443T1 (hr) * | 2008-06-23 | 2016-01-29 | Nippon Shinyaku Co., Ltd. | Terapijsko sredstvo protiv stenoze kralježniäśnog kanala |
| ES2762943T3 (es) * | 2015-09-03 | 2020-05-26 | Teva Pharmaceuticals Int Gmbh | Formas de Selexipag en estado sólido |
-
2022
- 2022-03-31 CA CA3215414A patent/CA3215414A1/en active Pending
- 2022-03-31 KR KR1020237034284A patent/KR20230165247A/ko active Pending
- 2022-03-31 IL IL307277A patent/IL307277A/en unknown
- 2022-03-31 TW TW111112395A patent/TW202304444A/zh unknown
- 2022-03-31 BR BR112023019899A patent/BR112023019899A2/pt unknown
- 2022-03-31 AU AU2022248664A patent/AU2022248664A1/en active Pending
- 2022-03-31 US US18/284,941 patent/US20240197724A1/en active Pending
- 2022-03-31 JP JP2023511724A patent/JPWO2022211052A1/ja active Pending
- 2022-03-31 CN CN202280023976.3A patent/CN117157075A/zh active Pending
- 2022-03-31 WO PCT/JP2022/016648 patent/WO2022211052A1/ja not_active Ceased
- 2022-03-31 EP EP22781262.5A patent/EP4316489A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL307277A (en) | 2023-11-01 |
| EP4316489A1 (en) | 2024-02-07 |
| WO2022211052A1 (ja) | 2022-10-06 |
| CN117157075A (zh) | 2023-12-01 |
| KR20230165247A (ko) | 2023-12-05 |
| TW202304444A (zh) | 2023-02-01 |
| AU2022248664A1 (en) | 2023-10-12 |
| EP4316489A4 (en) | 2025-03-26 |
| US20240197724A1 (en) | 2024-06-20 |
| BR112023019899A2 (pt) | 2023-11-07 |
| JPWO2022211052A1 (https=) | 2022-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5527205B2 (ja) | 脊柱管狭窄症治療剤 | |
| WO2009154246A1 (ja) | 勃起不全治療剤 | |
| KR101639821B1 (ko) | 염증성 장질환 치료제 | |
| JP7656574B2 (ja) | 甲状腺関連副作用を低下させる方法 | |
| US20020035128A1 (en) | Methods for treating parkinson's disease | |
| JPWO2009107736A1 (ja) | 線維化抑制剤 | |
| WO2009157397A1 (ja) | 非ステロイド性抗炎症剤投与に伴う腸管傷害治療剤 | |
| US20040180931A1 (en) | Methods for treating Parkinson's disease | |
| US6967211B2 (en) | Remedial agent for chronic articular rheumatism | |
| AU2005295511A1 (en) | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease | |
| EP4316489A1 (en) | Therapeutic agent for gait disturbance | |
| JP2872694B2 (ja) | 血管内血液凝固症候群の治療剤 | |
| HK40098771A (en) | Therapeutic agent for gait disturbance | |
| JP7010404B1 (ja) | 歩行障害治療剤 | |
| HK40096733A (zh) | 步态障碍治疗剂 | |
| WO2003022271A1 (fr) | Inhibiteur d'activation lymphocytaire et remede pour maladie auto-immune | |
| JPH0753363A (ja) | 頻尿治療剤 | |
| JP2002241311A (ja) | 界面活性剤を含む医薬組成物 | |
| JPH0366628A (ja) | 消化管運動賦活剤 | |
| JPH01250320A (ja) | ジヒドロピリジン化合物を含有する静脈伸展性改善剤および心肥大抑制剤 | |
| TW201440784A (zh) | 食後期之胃運動亢進劑 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251223 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251223 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20260313 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20260313 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260313 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260324 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260325 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20260325 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20260325 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20260325 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260325 |